Collagen & Peptide NutritionNutrition and collagen guides

Nutrition guide

Collagen Type I-C Telopeptide

Test Code QCTX Test Name Collagen Type I-C Telopeptide CPT Codes 82523 Expected Turnaround Time 3 - 5 days Clinical Utility For in vitro diagnostic use as an indicator of human bone resorption. This test may be used as an aid in monitoring bone resorption chan

Test Code
QCTX
Test Name
Collagen Type I-C Telopeptide
CPT Codes
82523
Expected Turnaround Time
3 - 5 days
Clinical Utility

For in vitro diagnostic use as an indicator of human bone resorption. This test may be used as an aid in monitoring bone resorption changes of antiresorptive therapies in postmenopausal women, individuals with osteopenia, and in predicting skeletal response (bone mineral density) in postmenopausal women undergoing antiresorptive therapies.

• Hormone replacement therapies (HRT) with hormones and hormone-like drugs

• Bisphosphonate therapies

Specimen and Container Info

Specimen Type: Serum

Collection Container: Gold Top, Serum Separator

Desired Specimen Volume: 0.5 mL

Collection Instructions
  1. It is recommended to draw blood as fasting, morning samples.
  2. Samples should not be taken from patients receiving therapy with high biotin doses (i.e. >5 mg/day) until at least 8 hours following the last biotin administration.
  3. Collect a gold top, serum separator tube via venipuncture.
Processing and Submission Instructions
  1. Separate serum from cells within 45 minutes of collection.
  2. Transfer 0.5 mL of serum to a LabCorp PP transpak frozen purple tube.
  3.  To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Patient Preparation

Morning/Fasting specimen preferred.

This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.

Transport Instructions

Transport to the laboratory frozen. 

Stability Requirements

Room Temperature

1 day

Refrigerated

14 days

Frozen

2 years

Freeze/Thaw Cycles

 Stable x6

Methodology
Electrochemiluminescence Immunoassay
Reference Intervals

 See patient report.

Limitations

This test is not intended to predict the development of osteoporosis or future fracture risk. The use of this test has not been established in hyperparathyroidism or hyperthyroidism. When using the test to monitor therapy, results may be confounded in patients afflicted with clinical conditions known to affect bone resorption (eg, bone metastases, hyperparathyroidism, or hyperthyroidism). Results should be interpreted in conjunction with clinical findings and other diagnostic results and should not be used as a sole determination in initiating or changing therapy. Note: Serum values are not interchangeable with urine values.

Alternate Names
  • Carboxyterminal Cross-linking Telopeptide of Bone Collagen
  • Collagen Cross-linked C-Telopeptide
  • Crosslaps
  • Type 1 Collagen
Reference Lab
Labcorp Of America Holdings
Testing Schedule
Monday-Friday
Original source

Use the original publication for full context and limitations.

Open source →